The Encyclopedia of ADDICTIVE DRUGS
Drug Types 29
- M.A. Herna ́ ndez-Mezquita et al., “Opinio ́ n de los directores escolares sobre la
influencia de factores del medio escolar en la actitud de nin ̃ os y jovenes ante el tabaco”
(Influence of school environment on student’s attitudes about tobacco consumption in
the opinion of the headmasters),Anales Espan ̃ oles de Pediatrı ́a52 (2000): 132–37 (abstract
in English).
- G.A. Giovino, “Epidemiology of Tobacco Use among U.S. Adolescents,”Nicotine
and Tobacco Research1 (1999, Suppl. 1): S31–S40.
- M.Y. Chong, K.W. Chan, and A.T. Cheng, “Substance Use Disorders among Ad-
olescents in Taiwan: Prevalence, Sociodemographic Correlates and Psychiatric Comor-
bidity,”Psychological Medicine29 (1999): 1387–96.
- N.A. Rigotti, J.E. Lee, and H. Wechsler, “U.S. College Students’ Use of Tobacco
Products: Results of a National Survey,”Journal of the American Medical Association 284
(2000): 699–705.
- C.H. Schenck and M.W. Mahowald, “Long-Term, Nightly Benzodiazepine Treat-
ment of Injurious Parasomnias and Other Disorders of Disrupted Nocturnal Sleep in
170 Adults,”American Journal of Medicine100 (1996): 333–37.
- D.A. Ciraulo, “Abuse Potential of Benzodiazepines,”Bulletin of the New York
Academy of Medicine61 (1985): 728–41.
- L. Walters and P. Nel, “Die Afhanklikheidspotensiaal van die Bensodiasepiene:
Toepassing van die Resultate van die Behandeling van die Alkoholonttrekkingsind-
room” (The addiction potential of benzodiazepines. Application of the results of treat-
ment of alcohol withdrawal syndrome),South African Medical Journal59 (1981): 115–16
(abstract in English). See also L. Walters and P. Nel, “Pharmacological Requirements
of Patients during Alcohol Withdrawal,”South African Medical Journal59 (1981): 114.
- A.H. Soderpalm and S. Hansen, “Benzodiazepines Enhance the Consumption
and Palatability of Alcohol in the Rat,”Psychopharmacology137 (1998): 215–22.
- In addition to other studies cited in this paragraph, see L. Laegreid, G. Hagberg,
and A. Lundberg, “The Effect of Benzodiazepines on the Fetus and the Newborn,”
Neuropediatrics23 (1992): 18–23.
- L. Laegreid, G. Hagberg, and A. Lundberg, “Neurodevelopment in Late Infancy
after Prenatal Exposure to Benzodiazepines—A Prospective Study,”Neuropediatrics 23
(1992): 60–67.
- L. Laegreid, “Clinical Observations in Children after Prenatal Benzodiazepine
Exposure,”Developmental Pharmacology and Therapeutics15 (1990): 186–88. See also G.
Viggedal, “Mental Development in Late Infancy after Prenatal Exposure to Benzodi-
azepines—A Prospective Study,”Journal of Child Psychology and Psychiatry, and Allied
Disciplines34 (1993): 295–305.
- U. Bergman et al., “Effects of Exposure to Benzodiazepine during Fetal Life,”
Lancet340 (1992): 694–96. See also J.A. Kuller et al., “Pharmacologic Treatment of Psy-
chiatric Disease in Pregnancy and Lactation: Fetal and Neonatal Effects,”Obstetrics and
Gynecology87 (1996): 789–94; S.D. Silberstein, “Headaches and Women: Treatment of
the Pregnant and Lactating Migraineur,”Headache33 (1993): 536.
- P.R. McElhatton, “The Effects of Benzodiazepine Use during Pregnancy and Lac-
tation,”Reproductive Toxicology8 (1994): 461–75.
- L. Stika et al., “Effects of Drug Administration in Pregnancy on Children’s School
Behaviour,”Pharmaceutisch Weekblad: Scientific Edition12 (1990): 252–55 (abstract in En-
glish).
- A. Czeizel, “Lack of Evidence of Teratogenicity of Benzodiazepine Drugs in Hun-
gary,”Reproductive Toxicology1 (1987–1988): 183–88. See also Kuller et al., “Pharma-
cologic Treatment of Psychiatric Disease in Pregnancy and Lactation: Fetal and
Neonatal Effects.”
- A. Ornoy et al., “Is Benzodiazepine Use during Pregnancy Really Teratogenic?”
